Clicky

HansBiomed Corporation(042520)

Description: HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea.


Keywords: Breast Cancer Bone Scar Skeletal System

Home Page: www.hansbiomed.com

7, Jeongui-ro 8-gil
Seoul,
South Korea
Phone: 82 2 466 2266


Officers

Name Title
Seok-Bae Oh Chief Financial Officer and Managing Director
Mr. Won-Gyun Kwon Sr. MD & Director
Guen Young Kim Chief Exec. Officer

Exchange: KQ

Country: KR : Korea (Republic of)

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 1.455
IPO Date:
Fiscal Year End: September
Full Time Employees: 0
Back to stocks